Suchergebnisse - (Subject:"angiotensin-converting enzyme inhibitors")

PubPharm (3.425)

1

Inferior vena cava collapsibility index as a predictor of hypotension after induction of general anesthesia in hypertensive patients

enthalten in: BMC anesthesiology | 2023

von Fathy, M. | Wahdan, R. | Salah, A. | +1

2

Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome : Impact on Prescription Practices

enthalten in: Pediatric cardiology | 2023

von Robertson, D. | Truong, D. | Cox, D. | +5

3

Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension : CALIBREX Trial

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2022

von Rogers, S. | Ko, Y. | Quyyumi, A. | +1

4

Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction : Findings from the HF-ACTION trial

enthalten in: American heart journal | 2022

von Pierce, J. | Mentz, R. | Sun, J. | +7

5

Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts

enthalten in: Cardiovascular diabetology | 2022

von Marfella, R. | D'Onofrio, N. | Mansueto, G. | +19

6

Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial

enthalten in: Stroke | 2022

von Maïer, B. | Gory, B. | Lapergue, B. | +39

7

In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients

enthalten in: The Journal of clinical investigation | 2021

von Li, S. | Sarangarajan, R. | Jun, T. | +10

CommentIn: J Clin Invest. 2022 Jan 18;132(2):. - PMID 34855622

8

Cardioprotective medication use in Black and white breast cancer survivors

enthalten in: Breast cancer research and treatment | 2021

von Sutton, A. | Felix, A. | Bandyopadhyay, D. | +3

9

COVID-19 as a trigger of acute attacks in people with hereditary angioedema

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2021

von Belbézier, A. | Arnaud, M. | Boccon-Gibod, I. | +8

10

β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

enthalten in: Allergy | 2021

von Sturm, G. | Herzog, S. | Aberer, W. | +36

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[343]